CombiGene AB (publ) COJ0.F Stock
CombiGene AB (publ) Price Chart
CombiGene AB (publ) COJ0.F Financial and Trading Overview
| CombiGene AB (publ) stock price | 0.25 EUR |
| Previous Close | 0.55 EUR |
| Open | 0.54 EUR |
| Bid | 0.55 EUR x N/A |
| Ask | 0.62 EUR x N/A |
| Day's Range | 0.54 - 0.54 EUR |
| 52 Week Range | 0.52 - 0.96 EUR |
| Volume | 200 EUR |
| Avg. Volume | 3 EUR |
| Market Cap | 11.31M EUR |
| Beta (5Y Monthly) | 1.305747 |
| PE Ratio (TTM) | 1.6333332 |
| EPS (TTM) | -0.15 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
COJ0.F Valuation Measures
| Enterprise Value | 11.07M EUR |
| Trailing P/E | 1.6333332 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
CombiGene AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.305747 |
| 52-Week Change | -22.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.96 EUR |
| 52 Week Low | 0.52 EUR |
| 50-Day Moving Average | 0.57 EUR |
| 200-Day Moving Average | 0.7 EUR |
COJ0.F Share Statistics
| Avg. Volume (3 month) | 3 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 19.8M |
| Float | 19.64M |
| Short Ratio | N/A |
| % Held by Insiders | 29.34% |
| % Held by Institutions | 1.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -108.34% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -84.21% |
| EBITDA Margin | -175.46% |
Management Effectiveness
| Return on Assets (ttm) | -12.095% |
| Return on Equity (ttm) | -12.34% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -84.70% |
| Gross Profit (ttm) | 9.18M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 21.44 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of CombiGene AB (publ)
| Country | Germany |
| State | N/A |
| City | Lidingö |
| Address | Agavagen 52A |
| ZIP | 181 55 |
| Phone | 46 7 04 66 31 63 |
| Website | https://www.combigene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Danish company Zyneyro to develop a treatment for chronic pain conditions; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.
Q&A For CombiGene AB (publ) Stock
What is a current COJ0.F stock price?
CombiGene AB (publ) COJ0.F stock price today per share is 0.25 EUR.
How to purchase CombiGene AB (publ) stock?
You can buy COJ0.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CombiGene AB (publ)?
The stock symbol or ticker of CombiGene AB (publ) is COJ0.F.
Which industry does the CombiGene AB (publ) company belong to?
The CombiGene AB (publ) industry is Biotechnology.
How many shares does CombiGene AB (publ) have in circulation?
The max supply of CombiGene AB (publ) shares is 23.45M.
What is CombiGene AB (publ) Price to Earnings Ratio (PE Ratio)?
CombiGene AB (publ) PE Ratio is now.
What was CombiGene AB (publ) earnings per share over the trailing 12 months (TTM)?
CombiGene AB (publ) EPS is -0.15 EUR over the trailing 12 months.
Which sector does the CombiGene AB (publ) company belong to?
The CombiGene AB (publ) sector is Healthcare.